Coivas review

The starting price leaves an important question open

Coivas advertises compounded semaglutide from $119 a month and compounded tirzepatide from $199 a month. Those are starting figures, not a confirmed quote for a selected dose, treatment term or renewal. The current public pages do not show a numeric ongoing rate. I would ask for the prescription, supply duration, full charge and next renewal amount together before paying. An oral option marked coming soon is not an available alternative today.

That distinction matters when comparing the lowest advertised GLP-1 offers. A starting price cannot tell me what a longer course costs. Earlier recorded ongoing prices are historical; I would not build a budget around them or assume the starting figure lasts indefinitely. The cost comparison guide helps separate a medication price from the complete plan.

What Coivas names and includes

The public homepage FAQ now identifies Beluga Health as its clinical network. That is a useful disclosure, but naming a network does not establish which clinician will handle an individual prescription or constitute an independent license review. I would ask who to contact for a treatment question and how follow-up works before relying on a general support promise.

Coivas describes consultation, prescription medication and ongoing support as included. Its current shipping policy explicitly includes free expedited shipping on every order, with a stated delivery time of 2–3 business days. That delivery estimate is not a promise about when a clinician will approve treatment. Lab requirements and any lab price remain unclear, so I would ask about them separately.

The refund promise requires a longer commitment

The homepage uses guaranteed-fat-loss and risk-free language. The terms describe a more specific Money Back Guarantee: at least six consecutive months of eligible treatment, continuous enrollment and a verified final weight at or above the starting weight. It is not a short trial that can be abandoned for a partial refund. Only compounded semaglutide and tirzepatide qualify; brand and microdose products are excluded.

Starting weight must be verified within seven days. Customers must complete required refill steps and not miss shipments. Claims are due within 40 days after the final shipment, with additional verification deadlines: a physician attestation within fourteen days or a code-based video within twenty-four hours. Attestation costs are not reimbursed. I would read the full eligibility rules and ask what evidence to keep before treating this promise as protection against the cost of trying treatment.

Price locks and cancellation need reading together

The FAQ qualifies its price lock with the same medication and treatment plan. The terms also allow price changes with 30 days’ notice. Those provisions may address different situations, so I would ask how they apply to my selected plan rather than assume either guarantees a permanent rate. Cancellation must happen before a shipment is processed; ask how to confirm that cutoff and receive confirmation.

I would compare the written answers with other provider reviews, especially the ongoing charge and any clinical follow-up requirements. The current public signup button opens with a health-goal question. Before continuing, I would obtain clear answers about the medication, next charge and refund eligibility rather than rely on a starting-price card.